Leriche; Caroline

Patent Applications and Registrations

Patent applications and USPTO patent grants for Leriche; Caroline.The latest application filed is for "aniline derivatives, their preparation and their therapeutic application".

Company Profile

0.14.14

Leriche; Caroline - Paris FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Aniline derivatives, their preparation and their therapeutic application Grant 9,624,159 - Feutrill , et al. April 18, 2	2017-04-18
Aniline Derivatives, Their Preparation And Their Therapeutic Application App 20160199330 - FEUTRILL; John ; et al.	2016-07-14
Aniline derivatives, their preparation and their therapeutic application Grant 9,249,085 - Feutrill , et al. February 2, 2	2016-02-02
Aniline Derivatives, Their Preparation And Their Therapeutic Application App 20140350019 - Feutrill; John ; et al.	2014-11-27
Diazepane acetamide derivatives as selective 11B-HSD1 inhibitors Grant 8,586,577 - Carniato , et al. November 19, 2	2013-11-19
NIP thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydroge-nase-1 Grant 8,546,575 - Leriche , et al. October 1, 2	2013-10-01
Heterocyclic Compounds, Their Preparation And Therapeutic Application App 20130123271 - Middlemiss; David ; et al.	2013-05-16
Substituted quinazoline compounds Grant 8,389,530 - Leriche , et al. March 5, 2	2013-03-05
Diazepane Acetamide Derivatives As Selective 11b-hsd1 Inhibitors App 20120283247 - CARNIATO; Denis ; et al.	2012-11-08
Diazepane-acetamide derivatives as selective 11.beta.-HSD1 inhibitors Grant 8,242,107 - Carniato , et al. August 14, 2	2012-08-14
Benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same Grant 8,232,272 - Botton , et al. July 31, 2	2012-07-31
2-adamantyl-butyramide derivatives as selective 11.beta.-HSD1 inhibitors Grant 8,183,265 - Roche , et al. May 22, 2	2012-05-22
Heterocyclic compounds App 20120041195 - Leriche; Caroline ; et al.	2012-02-16
Substituted Quinazoline Compounds App 20120004210 - Leriche; Caroline ; et al.	2012-01-05
Novel NIP Thiazole Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydroge-Nase-1 App 20110060007 - Leriche; Caroline ; et al.	2011-03-10
Novel Benzimidazoledihydrothiadiazinone Derivatives As Fructose-1,6-bisphosphatase Inhibitors, And Pharmaceutical Compositions Comprising Same App 20100286129 - Botton; Gerard ; et al.	2010-11-11
Diazepane-acetamide derivatives as selective 11B-HSD1 inhibitors App 20100069365 - Carniato; Denis ; et al.	2010-03-18
2-adamantyl-butyramide Derivatives As Selective 11beta-hsd1 Inhibitors App 20100022597 - Roche; Didier ; et al.	2010-01-28
Antidiabetic compounds comprising benzofuran and benzothiophene derivatives Grant 7,375,130 - Moinet , et al. May 20, 2	2008-05-20
Benzofurans and benzothiophenes Grant 7,371,774 - Moinet , et al. May 13, 2	2008-05-13
Antidiabetic compounds comprising benzofuran and benzothiophene derivatives App 20070078178 - Moinet; Gerard ; et al.	2007-04-05
Benzofurans and benzothiophenes App 20070066680 - Moinet; Gerard ; et al.	2007-03-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.